Strategies for Addressing Resistance and Off-Target Toxicity in Antibody-Drug ConjugatesFebruary 24, 2026
FDA Issues Plausible Mechanism Pathway Draft Guidance to Spur Innovation for Individualized TherapiesFebruary 24, 2026
DNA & Genetics Drug-Controlled CAR T Cells May Enable Safer ImmunotherapyBy adminFebruary 24, 20260 Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already…
